Back to Journals » ImmunoTargets and Therapy » Journal Metrics

PubMed
ESCI
SJR OA
CiteScore
Impact Factor

ImmunoTargets and Therapy

COPE logo
ISSN: 2253-1556

Usage:

  • 40,125 Annual downloads/views

Speed/ acceptance:

  • 56 days average from submission to first editorial decision
  • 6 days average from editorial acceptance to publication
  • 18% acceptance rate

Citation metrics:

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

  • 4.4 ((Q2) 2024) Impact Factor *
  • 7.9 (2024) 5 year Impact Factor
  • 8.6 ((Q1) 2024) CiteScore
  • 1.528 (2024) Source Normalized Impact per Paper (SNIP)
  • 2.291 (2024) Scimago Journal & Country Rank (SJR)
  • PubMed and PubMed Central (Immunotargets Ther)
  • Scopus, from 2022
  • Embase, from 2015
  • Directory of Open Access Journals (DOAJ)
  • The Open Access Initiative (OAIster)
*
  • Emerging Sources Citation Index (ESCI)

 

For more details, please read our journal metrics summary.